Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
Investcorp to Raise $403m in Abu Dhabi IPO
Investcorp Capital Plc and the Middle East’s biggest alternative asset manager, its parent, are looking to raise as much as 1.49bn dirhams ($403m) in an Abu Dhabi initial public offering. The price range for the investment vehicle was set at 1.90 dirhams to 2.30...
Morgan Stanley Bets Big on Music Copyrights with $700m Investment in Kobalt
Kobalt announced a new partnership with investment funds managed by Morgan Stanley Tactical Value to invest more than $700m to acquire music copyrights over the next few years. As part of the venture, Kobalt will manage the creative, synch, licensing, administration,...
Charlesbank Targets $1.25bn for Third Opportunistic Credit Fund
Charlesbank Capital Partners is aiming to raise $1.25bn for its third opportunistic credit fund, looking to invest in new corporate loans as well as to purchase them from other private credit shops to take advantage of market dislocations. The fundraising, which so...